PLx Pharma (NASDAQ: PLXP) may try to price their IPO this week. At the $18 mid-point of the proposed range the market capitalization would be about $180M. The lead underwriters are Raymond James and Maxim Group with Janney Montgomery on the cover as a co-manager. Feels like a very risky line up in this stock market. There at quite a few extra eggs in this basket too since many of the executives and consultants on the team have pinned their future compensation and contracts to the successful completion of the IPO. If the deal does get . . .